How to assess the external validity of therapeutic trials: A conceptual approach

International Journal of Epidemiology

Volumn 39, Issue 1, 2010, Pages 89-94

  Dekkers, O M ^a   von Elm, E ^b,c   Algra, A ^a,d,e   Romijn, J A ^a   Vandenbroucke, J P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinical trial; External validity

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CARVEDILOL; CLOPIDOGREL; TRANDOLAPRIL;

CONCEPTUAL FRAMEWORK; EPIDEMIOLOGY; METHODOLOGY;

ACUTE HEART INFARCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL STUDY; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; EXTERNAL VALIDITY; GEOGRAPHIC DISTRIBUTION; HEART FAILURE; HUMAN; HYPERTENSION; INTERNAL VALIDITY; METHODOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; STROKE; AGE; CLINICAL TRIAL; EPIDEMIOLOGY; REPRODUCIBILITY; SOCIOECONOMICS; STATISTICS; TIME;

AGE FACTORS; CLINICAL TRIALS AS TOPIC; EPIDEMIOLOGIC FACTORS; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SELECTION BIAS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 77952295734     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp174     Document Type: Article

References (24)

1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-1194.
2. Glasgow RE, Green LW, Klesges LM et al. External validity: we need to do more. Ann Behav Med 2006;31: 105-108.
3. Rothwell PM. External validity of randomised controlled trials: 'to whom do the results of this trial apply?' Lancet 2005;365:82-93.
4. O'Connell D, Glasziou PP, Hill S. How to Use the Evidence: Assessment and Application of Scientific Evidence. NHMRC, 2000. Canberra, Australia.
5. Shapiro SH, Weijer C, Freedman B. Reporting the study populations of clinical trials. Clear transmission or static on the line? J Clin Epidemiol 2000;53:973-979.
6. Chen ZM, Jiang LX, Chen YP et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-1621.
7. Brunner M, Cooper-DeHoff RM, Gong Y et al. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study). Am J Cardiol 2007;99:1549-54.
8. Steg PG, Lopez-Sendon J, Lopez dS et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007;167:68-73.
9. Al Shahi R, Vousden C, Warlow C. Bias from requiring explicit consent from all participants in observational research: prospective, population based study. Br Med J 2005;331:942.
10. Yuasa H, Kurita K, Westesson PL. External validity of a randomised clinical trial of temporomandibular disorders: analysis of the patients who refused to participate in research. Br J Oral Maxillofac Surg 2003;41:129-131.
11. Pablos-Mendez A, Barr RG, Shea S. Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998;279:222-225.
12. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-1355.
13. Materson BJ, Reda DJ, Cushman WC et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-921.
14. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20, 000 patients with acute ischaemic stroke. Lancet 1997;349:1641-1649.
15. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-1581.
16. Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008;168:103-108.
17. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19:1221-1230.
18. Travers J, Marsh S, Williams M et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 2007;62:219-223.
19. Travers J, Marsh S, Caldwell B et al. External validity of randomized controlled trials in COPD. Respir Med 2007;101:1313-1320.
20. Doll R, Hill AB. Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J 1956;2:1071-1081.
21. Weiss NS, Koepsell TD, Psaty BM. Generalizability of the results of randomized trials. Arch Intern Med 2008;168:133-135.
22. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341: 709-717.
23. Juurlink DN, Mamdani MM, Lee DS et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351: 543-551.
24. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott Williams & Wilkins, 1998.